N
Google TrendSOCIAL SECURITY 2027 COLA ANNOUNCEMENT (500+) — When will 2027’s Social Security COLA be announced?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:social security 2027 cola announcement500+benfica vs vitória sc200+energy ceasefire200+elliot anderson200+r.c.d. mallorca - u. d. las palmas200+quinyon mitchell2000+tornado north carolina1000+sean young500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Signatera Guides Bladder" (30 stories)

Top Headline Story

NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
Lead StoryCancerNetworkgeneral
Jun 23

NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOT0ZwRHVjdVhEWHBzNTFZTFVtTjRfV2tkRk1KZ1BZajctOUl4M1BZWWp3RV8zQU51VW9YSDVDWE9WYnUxR3FIOHA1UEFxWnYxRFEtdGZVOS1FM0FEZDk0ZUR5X1FpbXJzQVRrUmhVQWU0bkpFREVYYjJSa0gwTG16aDd3ek5QUUJwcEpNTkxWdXlwMThQZ2JNaTFQQQ?oc=5" target="_blank">NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+22m ago

social security 2027 cola announcement

When will 2027’s Social Security COLA be announced?

Filter stories
200+32m ago

benfica vs vitória sc

Benfica tem 'roupa nova' para receber o V. Guimarães: o onze provável

Filter stories
200+32m ago

energy ceasefire

Trump announces partial ceasefire in Ukraine war as Zelenskyy says deal is ‘news to me’

Filter stories
200+32m ago

elliot anderson

James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton

Filter stories

Search Results for "Signatera Guides Bladder"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx
Yahoo Financegeneral

Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOSWpLc1l4MWM3bEpEZWxnYjFnSmdEWUt0UjdNd0l3SUw0Mmt1R05zX1ZvNzdWaHdJUElRY3ZwMGJRd1pqM3hYLVhmVzFpZkQyaWFNOVBueXRaa2Z3OUtJSkpyTGJqT2RmOVBRenM4T3pTYkRDYmpvMzZrUkZhZ1pTUGl5cFF2S1ZNck4xWTZlQXEzakh3ZE1rMVJn?oc=5" target="_blank">Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
BioSpacegeneral

Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPM194My1kak1xTVNSMnR3S2RwdzhEaHFGY2pDankyWmN2bExMRnZnbjB1WGFRWFg2TlhWaXdSVktFVUxIdFg3cUdONkYxeXp4ZkJyOU9lT01uR1BHWGpQR2dxNzBhM3JkV0hWVkI3dWsxMmp5eE5JM1BMdkFzOEZHcEZCdVY0bDFTZWR2eTdsa2RYQjU5T3I4QWhMekNrT0NPckMxak5aUkV6WUxnNHhTd090U2h6T2JnTEdnS3ZGTVdib1p1cTI2ZVFLSS02Nm1IRUhVLWZyeGttLTRBNzUzVg?oc=5" target="_blank">Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer
Clinical Lab Productsgeneral

New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxONkNwdUZtbW5yOWh1bDBJOHpFZUxSaEJ2eXVYX2lzRjVnaU1aZ1NkVDU4cWhZalB2Tl82bkhjSzRINHhNQUJuZWlVMHlzblE2bWc1bUc4VExHbnVNQW5yX1ZCdjFnWWhFTTkyTGxvQ25uaHlUNmRneDByWWFqLTl5TnpweUJaYnRza3poM1pZSVUwaXZnUjV4Zkhn?oc=5" target="_blank">New Clinical Guidelines Recommend Molecular Testing for Bladder Cancer</a>  <font color="#6f6f6f">Clinical Lab Products</font>

Read Full StoryMore like this
NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy
Urology Timesgeneral

NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxOYm9DWTF2bmtxd3hHZ2NDbGk4NmJmTklaRk9rMFM1TDNUdEN4dmVBZllqX0ZrZGprZGp4RFNuaENJbTE1WUV2MGRvX0g2b3pDeDU5eU8zZkpySHg3ZmVrOU5lcE5rUFN6Qk1tM1cxZFo1UDVsTVJqQmJ4WTd2VUlqU0J4MnZlS0FLZmFJOUhnQk5hbTByejJYM2tfUjhuazNzVGItV3RJSFN1YXRJczUzcw?oc=5" target="_blank">NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care
Targeted Oncologygeneral

NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQaWtqYVJOVGVzcFAxUzBQTk9xTE5zeFlvMm56UTBDcExCVUtFRUN0Z2N6dkt1TjByamI2TkcwLXFobGdmRE4ta2FwUWFsNFVSZDRjV1N1RmZoV05rTzFiZVltRnRlWnphQU1RU2RLRUkyQnVKdXpDaFRQVm96MS0wX3BWRHp6QzF0NkNGeG1ETHlxXzQ?oc=5" target="_blank">NCCN Guidelines Recommend ctDNA-MRD Testing in MIBC Care</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Signatera Guides Bladder Cancer Treatment After Surgery
Cure Todaygeneral

Signatera Guides Bladder Cancer Treatment After Surgery

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPN3p5WmNEUXFfWW82OWM0ckUxZ3VLdVBLVUhtaTVPbjZzeWdRRDU5bThublYxQV8zZ1plVktqcHRrZmN4RmtPdEdXLWhiTzZNaDdISXp6MzBVMVNreHN1RzdJVXp1N19SbTQ1djk2ZTNKWEEwYlNGckF2OFBMaXJZUFd6ZlpsV0IxMy1kNkl1Yw?oc=5" target="_blank">Signatera Guides Bladder Cancer Treatment After Surgery</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval
Inside Precision Medicineworld

Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQQWwtZXBwM0hrSUJxc0NzdHlyOHUteHZkcHZOejN4RHh6NWlkLXJySFI1dzVjZXZ5bFZJZmRHSWhXbnVWSm5LX05hQ29PakRhREdjb0lIc0ZDV25JUnU1b0Q4ZnpEU3JUdFdZUGVEZnEzak9XdzhaVXFKZXdScTFWcnJLZmpsN21KdWhVVDFfbEp2aG1PTVFHSnF0X3lpdnA2UFRtWkRxMm5EUlNBeTJ5SjliVFBRRlAzOE1HZ2tzYVdkMEFHejFJZFdXR29CUThXUHQ0VlBKWmx2dw?oc=5" target="_blank">Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Read Full StoryMore like this
Tumor DNA May Help Guide Treatment for MIBC Surgery and Bladder-Sparing Therapy
Renal and Urology Newsgeneral

Tumor DNA May Help Guide Treatment for MIBC Surgery and Bladder-Sparing Therapy

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOTHpyUkJQS2dHZk1yclNRRl8tTVIxaEVGTGsxLXZPd0oxcF93VUpQdjRqZVFKRkRjYmt4TWJJLTM3SXczVDFHa1kwZHBRN20xdF9CbkpBWWctcDFBWnZDTkhNQ1pnaDhIcnJIY2l0enhqSy1OVU9hMk1nbkpjMVA4czFFYUFTUV9OdGVKSVVudVdET0hXVzdB?oc=5" target="_blank">Tumor DNA May Help Guide Treatment for MIBC Surgery and Bladder-Sparing Therapy</a>  <font color="#6f6f6f">Renal and Urology News</font>

Read Full StoryMore like this
NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm
OncLivegeneral

NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNU21xb3NTaHFLVHkyRE14YW9BN0oyc1RJZGtNMWRQRzlFalZBN3pLc2hIQVVpdGxtZndJMjNpMWdpa011c0JwQ0RQWlYwTG1hM1ltQkhpa1ZwejVQTXV2RElEejdjMUlJa0RuU3pscDVhdXZKSHg3MzJXRVVLaVRPX0pHM3c0SElQOWtNM3NyWGliZjhOTW1F?oc=5" target="_blank">NCCN Includes PCR ctDNA-MRD Testing in MIBC Treatment Algorithm</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment.
Stock Titangeneral

A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment.

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPX09lMlJVWE1pd25KY3lFa194eVExM1VsRUxOWlVLRVY4Ql9STzBCVGNJMnhrdkhyODY0TlduTGFEbEJiV0tNYmtzUHJ1NzFPcHJUNTBvdGk3UzlIOExBSktBV0xPUThTMjh4a04wbWR0aVpfNV8zTXVjVklCRkkzbXhMVEo2VURsS2lva2NyOHVDXzhUblBvUXk0NWJLRGZWR1F0c25SNXlnNFNFYUhMVTZvNHpZanc5REVrRQ?oc=5" target="_blank">A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment.</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
ctDNA Testing May Help More Patients Preserve Their Bladder
news.cancerconnect.comgeneral

ctDNA Testing May Help More Patients Preserve Their Bladder

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPbko3cG5aTHpxUkFYVy14bVF2Q2dnN0NZWFNCSUM3NmJQU2xQUHJwWDFsa3ZybnozdER6TW5wWWxZR2FKemxQYWx0TFFhcVhnQzFDdGl4ZDBLZEhYcW5yQ1J5T3lPNjV6S0ZFY3lTbDdHTk12aGdESDZuYUN6OEJrM2VNUDNNOW5FY2g0a0NHWE0xdldaNFE?oc=5" target="_blank">ctDNA Testing May Help More Patients Preserve Their Bladder</a>  <font color="#6f6f6f">news.cancerconnect.com</font>

Read Full StoryMore like this
Natera Hits 52-Week High as Japan Approves Signatera for Bladder Cancer
finance.biggo.comgeneral

Natera Hits 52-Week High as Japan Approves Signatera for Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9Qb1RpN3JJeDIwb2FoNmR1bVVEcjQwZURZQ2s1WmFUc3dzano5WDdsUFplNkg2bkx4Vk9iMUJRZ29GdS1YOFppeVpDd1BSRy1MZi01Tzk4X3VzaTB2Q2JjTnRNN3dzS1VLckxHeHpwN2Q1NmVIZ1E?oc=5" target="_blank">Natera Hits 52-Week High as Japan Approves Signatera for Bladder Cancer</a>  <font color="#6f6f6f">finance.biggo.com</font>

Read Full StoryMore like this
Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
MedTech Intelligencegeneral

Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer

<a href="https://news.google.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?oc=5" target="_blank">Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">MedTech Intelligence</font>

Read Full StoryMore like this
Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
Yahoo Financegeneral

Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQS2g4V041NUxJVnNOYVM4dnowck5BeGhCZ3E4bEJlNkxxTHNpRklyMGVIN2VnOTZZS1Y4dUllNjNOZ2ZfWlE3SHRnRWp4ZnY2dXBvcWkyV0N6ZVBrV2d5WXhJek9vaU44eVpIOTFfMEx4a3lEY0UwXzVjdHRxcEtTcGFHUUx4ektRZS1ldG5BUUYtS2YtVTlEUTdHd2g?oc=5" target="_blank">Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
Natera NTRA Jumps As NCCN Endorsement Fuels Bullish Targets
StocksToTradegeneral

Natera NTRA Jumps As NCCN Endorsement Fuels Bullish Targets

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE53WHF5bUZhdGdFN0Vub25ILXBTUjlKamlDNWV3TnRINS1zOUJ2X2RXeTRBUE85UkVoRndYR2c3bFZQdDZnalBYN2hlbWZfR3pRdHF2YWt5Ujk2UFBnLTJKWFlEcEgtMkpHcHFLbHN1MmRLVnc?oc=5" target="_blank">Natera NTRA Jumps As NCCN Endorsement Fuels Bullish Targets</a>  <font color="#6f6f6f">StocksToTrade</font>

Read Full StoryMore like this
Signatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC
OncLivegeneral

Signatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPcFppTzZZd2o2VEtLYkRCZUJmZ0lsT29pTmdGM3NYRjluclhzMDRLWHJKWW5hWmtOZXg2bjVIUXBMZGhZdkthc2duTXdjYWxpd1VBQUhvV3ZmNks1R3NHSy1JX3A1TkxnYUtRMzlsV19nZElONC1VUl9vOG9POVVJRDRUaS1RSEM3dWtqa3YzdGRQRWZabW9Mbi1LX1A4c1dmUFBJaXhVamU0LVhIeWc?oc=5" target="_blank">Signatera Is Submitted to Japan's PMDA for Companion Diagnostic Approval in MIBC</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
NCCN recommends Signatera for bladder cancer treatment
scanx.tradegeneral

NCCN recommends Signatera for bladder cancer treatment

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQM3dDMW9XTmwwQnlXZkpLTnVYRTBBSE1MNG92X1QwMC1OMGFOV3g4aHljSmhqUGZnMFhSM3VZVmM2R3BvbVV3QTNXU0V1MTVqWXZjX3lwVXZCeU9yMDBjR0pmR0NNeUNlSlkwVFdxNnZ1TkwwSDc2RzcyODJYcXdTakFuSnRrajAtU0kxMjlVTUI4U0EyMmhVenpTRHcwakM4MXZ0ZVAzM21QWEFxVTMtXw?oc=5" target="_blank">NCCN recommends Signatera for bladder cancer treatment</a>  <font color="#6f6f6f">scanx.trade</font>

Read Full StoryMore like this
Signatera-Guided Immunotherapy Improves Survival in Bladder Cancer Patients
news.cancerconnect.comworld

Signatera-Guided Immunotherapy Improves Survival in Bladder Cancer Patients

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOd3JFR0FBWlZkcVJrN19Xc09EWjdxdUNxR1c2dTFPUENGdThJdVo5eVNYU09KNlQ1V21aTlNEZWlpNG9naTdCVnRCZnpfY1NkbG95Zm40QWtsMXM0eEhlZUpfWV9RMEF3SmpiNVpTdm55d1RGY2hEQW8zSE5BUjhLdEl5dm5zS01sdW1PbFNXUGMzNDRYa3pzXzdBLS1VN3pLZ05XMEtmLXlXajg?oc=5" target="_blank">Signatera-Guided Immunotherapy Improves Survival in Bladder Cancer Patients</a>  <font color="#6f6f6f">news.cancerconnect.com</font>

Read Full StoryMore like this
Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer
CancerNetworkgeneral

Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOSG1qVnplaUJYNkZhTl94MVJoMUFlRk5qUjNOR05FX1c4MHNOdV9DdktuY0tDZ01VdWpXcVBpMHY5VGR0VkhmTjJWVVVpRG50ZFAzQjJrQ2FWNVQyM203Z1VIZTktbTdTMDd6LWxhU0NSenBZLVhtYWhTVHdfdEF0MzhlbUgzUURUZGFobm5FQ1ZxOVVkYkQwZkhlajFVZDFGdjMtYUE3cVMxRnY2?oc=5" target="_blank">Navigating ctDNA-Guided Decision-Making in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?
CancerNetworkgeneral

How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOVEZaNmRKT0hoSVVvVzZpVWNxeWUyZlpCY0MwR0RObkNkV3ZNZmRraWhMdWhzdU9ub2huNVlRdEpzVkM5VE0zOVNzUEZrLTR2YXp3YndDemtVZEY0VmltaFdybmFGQWJpRzg3Z1dUZVVYblo1YXBfWWplLXlQdklfbmhKc2d6MEgxaWV1M0NSRVIzOVIwZmVTbUdPQkxnbUtNa1gwLWJORQ?oc=5" target="_blank">How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Has the Future of Bladder Cancer Care Arrived? Molecular Testing May Change Adjuvant Strategies
Oncology News Centralgeneral

Has the Future of Bladder Cancer Care Arrived? Molecular Testing May Change Adjuvant Strategies

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNVHA0YTZuNnJ5V0MtYTZ5NGhIS1YwcTZLNllFT1ZfWjlrT29VakNPUk9VNkhaeHoyQ01COHFJZDRVM0tKb1ZBa1FOZ0hpQkY3dEdQbjVudFdUdmhjaDZST3F6MWpyREhfR1pWU29VWFdqb1ZTTmdybWVTUUxDbkRac3NkZjJBbnlVOVN1UHV1a1NOd2w2UTVhVDZFX3Y3MjlxLVA2eHpfdjA2RGRsM1BpbWdGdGVIRXJPajNxZWhsa1JEbzUwa0pubE5XWDdhMEl5NUgtdGoyVEdPdWVwM0E?oc=5" target="_blank">Has the Future of Bladder Cancer Care Arrived? Molecular Testing May Change Adjuvant Strategies</a>  <font color="#6f6f6f">Oncology News Central</font>

Read Full StoryMore like this
Natera seeks Japan’s PMDA approval for Signatera test in MIBC
Medical Device Networkgeneral

Natera seeks Japan’s PMDA approval for Signatera test in MIBC

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPTklHbDNWYnF3SzdJWFFlMlN5RDRjeVFxRDQyZmY2ZU5xZUlxdF9NVE9IWFEydHpUUHJ0Y2hXVGJURVk4X2F5bDF3UXRoVy1yUW9ZcFFVcHR5dV95SzBqalNsak9EdEhXNHVXREl4blJjQW1jbHVEN2toYXBQZjlsanlzQThWSVJK?oc=5" target="_blank">Natera seeks Japan’s PMDA approval for Signatera test in MIBC</a>  <font color="#6f6f6f">Medical Device Network</font>

Read Full StoryMore like this
Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)
BioSpacegeneral

Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxQS01IMGtLYWl2SVEybnp3RWlLWWFMRThFWkxnVHB4TzEwTG9tQTVwaGx4X2RTXzZ4YUxxRDRlUUkzZUt0OXllT0lKVWpDSEVjV0FzbWNuVnA0SWhGUjZXWDdKekM1aF9fRHdod1lHelBpdDhTX0RHX1N0QmdlVHM3ZjJLeTYxOUhKQjhDcnAyQ3NiakNfbktUNS1oVEg1SEw2OWJNV3JJbXRlWFBtUWN5YjZuaDVJbENOeUN6dG9HNS0zSkpYOU4tdkNmcHlEQTc3WVNHRw?oc=5" target="_blank">Signatera™ CDx Approved by the FDA as a Companion Diagnostic in Muscle-Invasive Bladder Cancer (MIBC)</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
FDA Approves MRD-Guided Use of Genentech's Tecentriq in Bladder Cancer With Natera Signatera CDx
Genome Webtech

FDA Approves MRD-Guided Use of Genentech's Tecentriq in Bladder Cancer With Natera Signatera CDx

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQVzVyb0pJcHFWcnhqMG9Cd3cwdmdpSjhIYTlJTlU4SzlRSjRERnZfOWpoNEFOVGRpM21PS1N4Nk9fNTc0RDNnMWZ6WkVZSjFEZzFhWmxGV29rRkJZdWtEeFN0N1lJb0R6UzVLaDFndTJtSWs1WjVHYXlxaS1qNTN2WFo1U0w2RHpFS2Z3VXNQNmVhT1VGQmpCNU1fOU9pWE5PNlFZOW5Ha05mUlJoTXpWOC1UN3c3TVp4WHc?oc=5" target="_blank">FDA Approves MRD-Guided Use of Genentech's Tecentriq in Bladder Cancer With Natera Signatera CDx</a>  <font color="#6f6f6f">Genome Web</font>

Read Full StoryMore like this
Natera’s Signatera Test Integrated into Phase III Bladder Cancer Trial
Clinical Lab Productsgeneral

Natera’s Signatera Test Integrated into Phase III Bladder Cancer Trial

<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxOQnhBTkJzQUNQM2pPYjQtV1FjODJRN1VwV3JSZ1VWZGRDbWQ1a1RFczZqbElHd3ZYTUlMSkhoMWpWWWZweUpmOXoxeFBzcGs0dHVEbmNPdmNLMnNRMHBTZHNKZWVGa3ZPbmhCbFgwVDBHUHg0SzJKVHRwMldMMUJJUE0tcTVHSkg1RVJ0RFlROF9TNldqU21KX0tLdENUMkFzMG9jdHVwRjBKMTFzbXc2OXpUdmtJdENFS1otRkJHUUNJMzF5V0dzVXgwc1VoTVhKSWk4dXNPYTFoN0JCa1NUVHhKU2tobXViMzA0SHdnY05UcmM?oc=5" target="_blank">Natera’s Signatera Test Integrated into Phase III Bladder Cancer Trial</a>  <font color="#6f6f6f">Clinical Lab Products</font>

Read Full StoryMore like this
Drs Uzzo, Chung, and Croll’s Takeaways From ASCO GU 2026
Renal and Urology Newsworld

Drs Uzzo, Chung, and Croll’s Takeaways From ASCO GU 2026

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE1WWUh5N05hcXc1YUpKYzRfWmFob2txSHY5Rjh5dnJvQzNmOUxzeTNaa2JjdTAwNFFVampVbnpTdXJtVUlWd0pEeW9sXzM2U0ExbHVXZGxhMjM3NVU1a3F4VEZWaHJHMS1MMWlLaHM1LTI5aEdkRUYtY0Zn?oc=5" target="_blank">Drs Uzzo, Chung, and Croll’s Takeaways From ASCO GU 2026</a>  <font color="#6f6f6f">Renal and Urology News</font>

Read Full StoryMore like this
Natera Files FDA PMA for Signatera CDx in Muscle-Invasive Bladder Cancer
Oncodailygeneral

Natera Files FDA PMA for Signatera CDx in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE13WFhSR2RXeXp4YUwxelhPYUU1RmZUYWZvS1JzREhwZDdydnhkMmNvN3VtSVFPUUhOc0wwT3dROXJMckFhRkpCYTBES3JMVE8xZTU4OTI1c2Q0eDdkUTlIM2R3?oc=5" target="_blank">Natera Files FDA PMA for Signatera CDx in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
Natera Celebrates Major Milestones for Signatera in Bladder and Colorectal Cancer
Oncodailygeneral

Natera Celebrates Major Milestones for Signatera in Bladder and Colorectal Cancer

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE95cVlqeFUwUk9lcC1GQWNINndMc29IeHFYbUdEa3RwSzhZZldOSkRydTYxY3NvZXlITHpNNVR5d1RjNk5ER1JzQWNhSk40aVJDbXAwUg?oc=5" target="_blank">Natera Celebrates Major Milestones for Signatera in Bladder and Colorectal Cancer</a>  <font color="#6f6f6f">Oncodaily</font>

Read Full StoryMore like this
NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer
Yahoo Financegeneral

NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPRGFoLVM1WFpYQzI3N3A5RU1DM2xXNm9xQkZXc2RDNXRVUmZyNHU4akQ2ay1LeU95bTJVMW9EX0xVenZSYS1ic1RCb01uVGlPcGV4V1B1YlpmWVExNTNHQ3l5ME5Xa3QyaGRmSm5MVVlUWmQxRW1iWXllMUFvdmlLdG8wUlFWMVJ4QkEwZ3d5MjRNYjY1aE9oOWxGUmk4QQ?oc=5" target="_blank">NTRA's Signatera CDx Wins FDA Nod in Muscle-Invasive Bladder Cancer</a>  <font color="#6f6f6f">Yahoo Finance</font>

Read Full StoryMore like this
"Signatera Guides Bladder" — Live Google News Trends & Headlines